Serve H - Search Results

1

Expression of a AC133, a novel stem cell marker, on human leukemic blasts lacking CD34-antigen and on a human CD34+ leukemic line:MUTZ-2.

Kratz-Albers K, Zühlsdorp M, Leo R, Berdel WL, Büchner T, Serve H. Kratz-Albers K, et al. Among authors: serve h. Blood. 1998 Dec 1;92(11):4485-7. Blood. 1998. PMID: 9882101 Free article. No abstract available.

2

Constitutive activation of FLT3 in acute myeloid leukaemia and its consequences for growth of 32D cells.

Fenski R, Flesch K, Serve S, Mizuki M, Oelmann E, Kratz-Albers K, Kienast J, Leo R, Schwartz S, Berdel WE, Serve H. Fenski R, et al. Among authors: serve s, serve h. Br J Haematol. 2000 Feb;108(2):322-30. doi: 10.1046/j.1365-2141.2000.01831.x. Br J Haematol. 2000. PMID: 10691863 Free article.

3

Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma.

Dankbar B, Padró T, Leo R, Feldmann B, Kropff M, Mesters RM, Serve H, Berdel WE, Kienast J. Dankbar B, et al. Among authors: serve h. Blood. 2000 Apr 15;95(8):2630-6. Blood. 2000. PMID: 10753844 Free article.

4

Functional response of leukaemic blasts to stromal cell-derived factor-1 correlates with preferential expression of the chemokine receptor CXCR4 in acute myelomonocytic and lymphoblastic leukaemia.

Möhle R, Schittenhelm M, Failenschmid C, Bautz F, Kratz-Albers K, Serve H, Brugger W, Kanz L. Möhle R, et al. Among authors: serve h. Br J Haematol. 2000 Sep;110(3):563-72. doi: 10.1046/j.1365-2141.2000.02157.x. Br J Haematol. 2000. PMID: 10997965 Free article.

5

Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathways.

Mizuki M, Fenski R, Halfter H, Matsumura I, Schmidt R, Müller C, Grüning W, Kratz-Albers K, Serve S, Steur C, Büchner T, Kienast J, Kanakura Y, Berdel WE, Serve H. Mizuki M, et al. Among authors: serve s, serve h. Blood. 2000 Dec 1;96(12):3907-14. Blood. 2000. PMID: 11090077 Free article.

6

Simultaneous immunomagnetic CD34+ cell selection and B-cell depletion in peripheral blood progenitor cell samples of patients suffering from B-cell non-Hodgkin's lymphoma.

Mohr M, Dalmis F, Hilgenfeld E, Oelmann E, Zühlsdorf M, Kratz-Albers K, Nolte A, Schmitmann C, Onaldi-Mohr D, Cassens U, Serve H, Sibrowski W, Kienast J, Berdel WE. Mohr M, et al. Among authors: serve h. Clin Cancer Res. 2001 Jan;7(1):51-7. Clin Cancer Res. 2001. PMID: 11205918

7

Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease.

Schnittger S, Schoch C, Dugas M, Kern W, Staib P, Wuchter C, Löffler H, Sauerland CM, Serve H, Büchner T, Haferlach T, Hiddemann W. Schnittger S, et al. Among authors: serve h. Blood. 2002 Jul 1;100(1):59-66. doi: 10.1182/blood.v100.1.59. Blood. 2002. PMID: 12070009 Free article.

8

Receptor for platelet-activating factor (PAF) is not detectable by flow cytometry on the surface of myeloid leukemic cells.

Berdel WE, Kulimova E, Kolkmeyer A, Zühlsdorf M, Serve H, Büchner T, Oelmann E. Berdel WE, et al. Among authors: serve h. Ann Hematol. 2005 Nov;84(12):771-3. doi: 10.1007/s00277-005-1088-3. Epub 2005 Nov 12. Ann Hematol. 2005. PMID: 16094532

9

Dose-dense induction with sequential high-dose cytarabine and mitoxantone (S-HAM) and pegfilgrastim results in a high efficacy and a short duration of critical neutropenia in de novo acute myeloid leukemia: a pilot study of the AMLCG.

Braess J, Spiekermann K, Staib P, Grüneisen A, Wörmann B, Ludwig WD, Serve H, Reichle A, Peceny R, Oruzio D, Schmid C, Schiel X, Hentrich M, Sauerland C, Unterhalt M, Fiegl M, Kern W, Buske C, Bohlander S, Heinecke A, Baurmann H, Beelen DW, Berdel WE, Büchner T, Hiddemann W. Braess J, et al. Among authors: serve h. Blood. 2009 Apr 23;113(17):3903-10. doi: 10.1182/blood-2008-07-162842. Epub 2009 Jan 8. Blood. 2009. PMID: 19131552 Free article. Clinical Trial.

10

E3 ligase-defective Cbl mutants lead to a generalized mastocytosis and myeloproliferative disease.

Bandi SR, Brandts C, Rensinghoff M, Grundler R, Tickenbrock L, Köhler G, Duyster J, Berdel WE, Müller-Tidow C, Serve H, Sargin B; Study Alliance Leukemias. Bandi SR, et al. Among authors: serve h. Blood. 2009 Nov 5;114(19):4197-208. doi: 10.1182/blood-2008-12-190934. Epub 2009 Sep 4. Blood. 2009. PMID: 19734451 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

374 results

Search Page

Filters